M. Castillo-Palma

发表

Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.

N. Ortego-Centeno, A. Guillén-del Castillo, V. Fonollosa-Plá, 2017, Autoimmunity reviews.

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

N. Ortego-Centeno, A. Selva-O'Callaghan, M. Ramos-Casals, 2011, Arthritis research & therapy.

Survival in pulmonary hypertension in Spain: insights from the Spanish registry

J. Barberà, M. Gómez-Sánchez, J. Segovia, 2012, European Respiratory Journal.

Screening for PAH in patients with systemic sclerosis: focus on Doppler echocardiography.

O. Kowal‐Bielecka, C. Opitz, D. Pittrow, 2008, Rheumatology.

Pulmonary hypertension in Spanish patients with systemic sclerosis. Data from the RESCLE registry

N. Ortego-Centeno, A. Guillén-del Castillo, V. Fonollosa-Plá, 2018, Clinical Rheumatology.

Tocilizumab for treating refractory haemolytic anaemia in a patient with systemic lupus erythematosus.

J. Sánchez-Román, M. Castillo-Palma, F. García-Hernández, 2012, Rheumatology.

Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

J. Callejas-Rubio, N. Ortego-Centeno, V. Fonollosa-Plá, 2012, Seminars in arthritis and rheumatism.

Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.

J. C. Callejas Rubio, A. Guillén-del Castillo, V. Fonollosa-Plá, 2016, Seminars in arthritis and rheumatism.

Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.

N. Ortego-Centeno, A. Guillén-del Castillo, V. Fonollosa-Plá, 2017, Seminars in arthritis and rheumatism.

Registry of the Spanish Network for Systemic Sclerosis

J. Callejas-Rubio, N. Ortego-Centeno, V. Fonollosa-Plá, 2015, Medicine.

First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study

N. Ortego-Centeno, L. Sáez Cómet, J. J. Ríos Blanco, 2018, Clinical Rheumatology.

Association of CCR 5 Δ 32 and Behçet ’ s disease : new data from a case-control study in the Spanish population and meta-analysis

N. Ortego-Centeno, G. Espinosa, S. Castañeda, 2015 .

HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population

Javier Martín, M. González-Gay, N. Ortego-Centeno, 2013, Arthritis Research & Therapy.

Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus

M. González-Escribano, M. Rodríguez, M. Castillo-Palma, 2014, Lupus.

Evaluation of the immunomodulatory effect of melatonin on the T‐cell response in peripheral blood from systemic lupus erythematosus patients

Josep M. Guerrero, A. Carrillo-Vico, M. Castillo-Palma, 2015, Journal of pineal research.

Overexpression of the Cytokine BAFF and Autoimmunity Risk

Joseph H. Marcus, G. Abecasis, D. Schlessinger, 2017, The New England journal of medicine.

Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease.

Javier Martín, M. González-Gay, N. Ortego-Centeno, 2013, Human immunology.

GIMAP and Behçet disease: no association in the European population

Javier Martín, M. González-Gay, N. Ortego-Centeno, 2014, Annals of the rheumatic diseases.

Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross‐sectional study

R. Ríos-Fernandez, N. Ortego-Centeno, J. Sabio, 2017, International journal of rheumatic diseases.

Pulmonary capillary hemangiomatosis as cause of pulmonary hypertension in a young woman with systemic lupus erythematosus.

J. Sánchez-Román, M. Castillo-Palma, J. Fernández-Alonso, 1999, The Journal of rheumatology.

Biologics use in sle in 23 centers – data from the international registry for biologics in SLE

D. Isenberg, M. Petri, C. Pineau, 2011 .